June 29, 2026

BioNTech SE (BNTX) Investor Outlook: Potential Upside of 33.49% Amidst Revenue Challenges

BioNTech SE (BNTX), headquartered in Mainz, Germany, has become a prominent name in the biotechnology sector, particularly known for its groundbreaking work in immunotherapies and mRNA vaccine development. While its..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a Potential 42.74% Upside in the Healthcare Sector

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software solutions for the life sciences industry, is catching the attention of investors with a potential upside of 42.74%, as indicated..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Unpacking its 6.02% Upside Potential

Investors seeking opportunities in the healthcare sector might find Zimmer Biomet Holdings, Inc. (NYSE: ZBH) an intriguing option. With a market capitalization of $18.01 billion, this U.S.-based medical device company..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Healthcare Giant with 39.78% Upside Potential

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading player in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors looking to capitalize on the growing..

Alcon Inc. (ALC) Stock Analysis: A Healthcare Giant with a 29.68% Upside Potential

For investors with an eye on the healthcare sector, Alcon Inc. (ALC) presents a compelling opportunity. Headquartered in Geneva, Switzerland, Alcon is a leader in the medical instruments and supplies..

Amgen Inc. (AMGN)

⚠️ No article content returned.

..

The Cigna Group (CI) Stock Analysis: Exploring a 20% Potential Upside for Investors

The Cigna Group (NYSE: CI), a prominent player in the healthcare sector, stands as a compelling choice for investors seeking both stability and growth potential in their portfolios. As of..

argenx SE (ARGX) Stock Analysis: An Upside of 17.57% Awaits Investors in Biotech Powerhouse

argenx SE (NASDAQ: ARGX), a leading player in the biotechnology sector, has garnered significant attention from investors thanks to its robust growth metrics and promising product pipeline. Headquartered in Amsterdam,..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Growth Prospects Amid a 1.35% Potential Upside

Merck & Company, Inc. (NYSE: MRK) stands as a formidable player in the healthcare sector, with a market capitalization of $317.77 billion. Based in the United States, Merck operates globally,..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with 11.67% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to capture the attention of investors in the biotechnology sector. With a current market cap of $124.7 billion, Vertex stands as a significant player..

Agilent Technologies, Inc. (A) Stock Analysis: Unpacking a 17.88% Potential Upside for Investors

Agilent Technologies, Inc. (NYSE: A), a pivotal player in the Healthcare sector, stands out in the Diagnostics & Research industry with a commendable market capitalization of $38.41 billion. As the..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 29% Upside with a Robust Dividend Yield

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, commands attention with its rich history dating back to 1781. Headquartered in Chuo, Japan, Takeda has carved..

Stryker Corporation (SYK) Stock Analysis: Exploring a 16.26% Potential Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a significant market capitalization of $127.55 billion, Stryker is a..

Thermo Fisher Scientific Inc (TMO)

⚠️ No article content returned.

..

Eli Lilly (LLY) Stock Analysis: A Trillion-Dollar Giant with Robust Revenue Growth and Strong Buy Ratings

Eli Lilly and Company (NYSE: LLY) stands tall as a formidable player in the healthcare sector, specifically within the drug manufacturers industry. With a staggering market capitalization of $1.08 trillion,..

Cencora, Inc. (COR) Stock Analysis: Evaluating the 22.67% Upside Potential in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a prominent player in the medical distribution industry, presents a compelling investment opportunity for those eyeing the healthcare sector. Formerly known as AmerisourceBergen Corporation, Cencora has..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a Potential 20% Upside Amidst Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE) remains a prominent player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $138.44 billion, the company is a heavyweight..

AbbVie Inc. (ABBV) Stock Analysis: Navigating a $447.62 Billion Market Cap with Solid Growth and Dividends

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its robust market cap of $447.62 billion. As a research-based biopharmaceutical company, AbbVie engages..

Abbott Laboratories (ABT) Stock Analysis: Potential 23.82% Upside Amid Strong Buy Ratings

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, remains a compelling investment opportunity for individual investors seeking exposure to the dynamic medical devices industry. With a commanding market..

ITcare expands its DDoS defence capability with Corero partnership

ITcare’s new Corero partnership broadens its DDoS protection capability, giving infrastructure customers more flexible options for detection, mitigation and ongoing network resilience...
Search

Funds

June 29, 2026

ITcare expands its DDoS defence capability with Corero partnership

ITcare’s new Corero partnership broadens its DDoS protection capability, giving infrastructure customers more flexible options for detection, mitigation and ongoing network resilience...
Search

Funds

June 29, 2026

FTSE 100

Funds